🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07244276
Recruiting Not applicable

Comparison of Compressed Continuous Suture and Conventional Suture in Pterygium Surgery

NCT07244276 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Eye Hospital
Phase
Not applicable
Started
2024-04-02
Last updated
2025-11-24

Condition(s) studied

Primary Pterygium

Investigational drug(s) / intervention(s)

Compression continuous suture with suture crimpingConventional Suture with suture crimping

Compression continuous suture with suture crimping: Pterygium excision combined with autologous conjunctival transplantation was performed, and the continuous suture method with pressure lines was adopted during the operation

Conventional Suture with suture crimping: Pterygium excision combined with autologous conjunctival transplantation was performed, and the traditional suture method was adopted during the operation

Study summary

To compare the advantages and disadvantages of continuous suture with suture and conventional Suture in primary pterygium surgery for autologous conjunctival graft fixation

Eligibility

Sex
ALL
Min age
30 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Diagnosis of primary pterygium according to diagnostic criteria; 2. The pterygium head invades the cornea by 2-5mm; 3. The patient agrees to the surgical treatment and signs the surgical consent form. Exclusion Criteria: 1. History of previous eye surgery; 2. Have active ocular inflammatory lesions; 3. recurrent and pseudopterygium; 4. The patient refuses surgery or is unable to have regular follow-ups

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tianjin Eye Hospital Tianjin Tianjin Municipality Recruiting

More Tianjin Eye Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07244276 on ClinicalTrials.gov ↗ ← All trials in China